ID: h-debate-0425e09671f7
Hypothesis

RNA Splicing Corrector Compounds

Disease-modifying therapies targeting aberrant splicing patterns common to ALS, FTD, and AD could restore proper mRNA processing.
🧬 TARDBP🎯 Composite 0%💱 $0.51▲1.1%proposed
neurodegeneration
EvidenceModerate (50%)📖 0 cit🗣 1 debates 1 support 0 oppose
✓ All Quality Gates Passed
Mechanistic 0.60 (15%) Evidence 0.55 (15%) Novelty 0.60 (12%) Feasibility 0.00 (12%) Impact 0.00 (12%) Druggability 0.00 (10%) Safety 0.00 (8%) Competition 0.00 (6%) Data Avail. 0.00 (5%) Reproducible 0.00 (5%) KG Connect 0.50 (8%) 0.000 composite

🧪 Overview

Disease-modifying therapies targeting aberrant splicing patterns common to ALS, FTD, and AD could restore proper mRNA processing. Antisense oligonucleotides or small molecules could correct cryptic splicing events caused by RBP dysfunction.

Debate provenance: derived from debate `sess_sda-2026-04-01-gap-v2-68d9c9c1` on question: RNA binding protein dysregulation across ALS FTD and AD. Consensus signal: skeptic, synthesizer, theorist discussed the mechanism terms ALS, Compounds, Corrector, FTD, RBP, RNA, Splicing, TARDBP. Novelty signal: skeptic-discussed-with-qualified-concession.

🧬 Mechanism

🔗 Mechanism from KG for TARDBP

Auto-built from this analysis's top knowledge-graph edges.

graph TD
    TARDBP["TARDBP"] -->|risk factor for| ALS_FTD["ALS-FTD"]
    SETX["SETX"] -->|co discussed| TARDBP_1["TARDBP"]
    TARDBP_2["TARDBP"] -->|co discussed| HNRNPA2B1["HNRNPA2B1"]
    TARDBP_3["TARDBP"] -->|co discussed| NPM1["NPM1"]
    TARDBP_4["TARDBP"] -->|co discussed| SYNCRIP["SYNCRIP"]
    APOE4["APOE4"] -->|co discussed| TARDBP_5["TARDBP"]
    TARDBP_6["TARDBP"] -->|co discussed| TREM2["TREM2"]
    NPM1_7["NPM1"] -->|co discussed| TARDBP_8["TARDBP"]
    TARDBP_9["TARDBP"] -->|co discussed| SETX_10["SETX"]
    HNRNPA2B1_11["HNRNPA2B1"] -->|co discussed| TARDBP_12["TARDBP"]
    SYNCRIP_13["SYNCRIP"] -->|co discussed| TARDBP_14["TARDBP"]
    G3BP1["G3BP1"] -->|co associated with| TARDBP_15["TARDBP"]
    HNRNPA2B1_16["HNRNPA2B1"] -->|co associated with| TARDBP_17["TARDBP"]
    SETX_18["SETX"] -->|co associated with| TARDBP_19["TARDBP"]
    SYNCRIP_20["SYNCRIP"] -->|co associated with| TARDBP_21["TARDBP"]
    style TARDBP fill:#ce93d8,stroke:#333,color:#000
    style ALS_FTD fill:#ef5350,stroke:#333,color:#000
    style SETX fill:#ce93d8,stroke:#333,color:#000
    style TARDBP_1 fill:#ce93d8,stroke:#333,color:#000
    style TARDBP_2 fill:#ce93d8,stroke:#333,color:#000
    style HNRNPA2B1 fill:#ce93d8,stroke:#333,color:#000
    style TARDBP_3 fill:#ce93d8,stroke:#333,color:#000
    style NPM1 fill:#ce93d8,stroke:#333,color:#000
    style TARDBP_4 fill:#ce93d8,stroke:#333,color:#000
    style SYNCRIP fill:#ce93d8,stroke:#333,color:#000
    style APOE4 fill:#ce93d8,stroke:#333,color:#000
    style TARDBP_5 fill:#ce93d8,stroke:#333,color:#000
    style TARDBP_6 fill:#ce93d8,stroke:#333,color:#000
    style TREM2 fill:#ce93d8,stroke:#333,color:#000
    style NPM1_7 fill:#ce93d8,stroke:#333,color:#000
    style TARDBP_8 fill:#ce93d8,stroke:#333,color:#000
    style TARDBP_9 fill:#ce93d8,stroke:#333,color:#000
    style SETX_10 fill:#ce93d8,stroke:#333,color:#000
    style HNRNPA2B1_11 fill:#ce93d8,stroke:#333,color:#000
    style TARDBP_12 fill:#ce93d8,stroke:#333,color:#000
    style SYNCRIP_13 fill:#ce93d8,stroke:#333,color:#000
    style TARDBP_14 fill:#ce93d8,stroke:#333,color:#000
    style G3BP1 fill:#ce93d8,stroke:#333,color:#000
    style TARDBP_15 fill:#ce93d8,stroke:#333,color:#000
    style HNRNPA2B1_16 fill:#ce93d8,stroke:#333,color:#000
    style TARDBP_17 fill:#ce93d8,stroke:#333,color:#000
    style SETX_18 fill:#ce93d8,stroke:#333,color:#000
    style TARDBP_19 fill:#ce93d8,stroke:#333,color:#000
    style SYNCRIP_20 fill:#ce93d8,stroke:#333,color:#000
    style TARDBP_21 fill:#ce93d8,stroke:#333,color:#000

⚖️ Evidence

📖 Linked Papers

No linked papers recorded for this hypothesis yet.

🏥 Translation

🧬 3D Protein Structure — TARDBP

🧬 PDB 4BS2 Click to expand

Experimental structure from RCSB PDB | Powered by Mol*

💉 Clinical Trials

No clinical trials data linked to this hypothesis yet.

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

🔍 Search ClinVar for TARDBP →

No DepMap CRISPR Chronos data found for TARDBP.

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

🏆 Tournament

🏆 Arenas / Elo

No arena matches recorded yet. Browse Arenas →

📊 Market Indicators

7d Trend
Stable
7d Momentum
▲ 0.0%
Volatility
Low
0.0002
Events (7d)
1
Price History
▲1.1%

💾 Resource Usage

LLM Tokens
16,494
$0.0770
Total Cost
$0.0770
Metadatasource: v1_phase_c_backfill · origin_type: debate_round_mining
sourcev1_phase_c_backfill
origin_typedebate_round_mining
_schema_version1
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting 0 contradicting 0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.